73 related articles for article (PubMed ID: 2626971)
1. The effect of parathyroid hormone and 1,25 (OH)2D3 on nerve conductance in patients on maintenance hemodialysis.
Ivić MA; Kostić S; Strahinjić S; Stefanović V
Acta Med Iugosl; 1989; 43(5):349-55. PubMed ID: 2626971
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
4. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
[TBL] [Abstract][Full Text] [Related]
5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
6. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
[TBL] [Abstract][Full Text] [Related]
7. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
10. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
Avram MM; Feinfeld DA; Huatuco AH
N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
12. Peripheral motor and sensory nerve conduction studies in haemodialysis patients. A study of 54 patients.
Van den Neucker K; Vanderstraeten G; Vanholder R
Electromyogr Clin Neurophysiol; 1998 Dec; 38(8):467-74. PubMed ID: 9842481
[TBL] [Abstract][Full Text] [Related]
13. Central sensory motor pathways are less affected than peripheral in chronic renal failure.
Kalita J; Misra UK; Rajani M; Kumar A
Electromyogr Clin Neurophysiol; 2004; 44(1):7-10. PubMed ID: 15008018
[TBL] [Abstract][Full Text] [Related]
14. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
15. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
16. Second lumbrical-interossei latency difference: A strong predictor of median neuropathy at the wrist in uremic patients.
Sharma VK; Wilder-Smith EP
Neurol Neurophysiol Neurosci; 2007 Jul; ():2. PubMed ID: 17700926
[TBL] [Abstract][Full Text] [Related]
17. Nerve conduction studies and prediction of mortality in hemodialysis patients.
Stosovic M; Nikolic A; Stanojevic M; Simic-Ogrizovic S; Radovic M; Jovanovic D; Popovic Z; Trikic R; Djukanovic L
Ren Fail; 2008; 30(7):695-9. PubMed ID: 18704818
[TBL] [Abstract][Full Text] [Related]
18. [Increased in vitro and ex vivo proliferation of erythroid precursors induced by calcitriol in chronic renal failure. Synergistic effect with rHuEPO].
Aucella F; Gatta G; Vigilante M; Scalzulli RP; Mantuano S; Carotenuto M; Stallone C
G Ital Nefrol; 2002; 19(2):137-42. PubMed ID: 12195411
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
[TBL] [Abstract][Full Text] [Related]
20. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]